Disclosures for "Novel Fusion GNAI2::BRAF as Driver for Pilocytic Astrocytoma: A Case Report "
-
Dr. Minor has nothing to disclose.
-
Dr. Chamberlin has nothing to disclose.
-
Dr. Low has nothing to disclose.
-
Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astellas Gene Therapies (formerly Audentes Therapeutics, Inc.). The institution of Dr. Jones has received research support from NIH.
-
Mr. Stevenson has nothing to disclose.
-
An immediate family member of Dr. Jeck has received personal compensation for serving as an employee of Seagen Inc. The institution of Dr. Jeck has received research support from Priya Therapeutics.
-
Dr. Smith has nothing to disclose.